AVR and AVR.AX Related Headlines
Go Back- Anteris adds two directors to board
- Anteris Appoints Susan Knight and Stephen Denaro to its Board of Directors
- Anteris Announces Results for the First Quarter of 2026
- Anteris Technologies Announces First U.S. Patients Treated in Global Pivotal PARADIGM Trial
- Anteris Technologies Secures CMS Reimbursement Supporting U.S. Site Activation for PARADIGM Trial
- Anteris receives $90 million strategic investment from Medtronic
- Anteris Announces Strategic Investment from Medtronic to Continue Advancing TAVR in $320 Million Aggregate Capital Raises
- Anteris Technologies closes $320 million stock offering and private placement
- Anteris Technologies Global Corp. Announces Closing of $230 Million Public Offering of Common Stock
- Anteris Technologies prices $200 million public offering at $5.75 per share
- Anteris Technologies prices $200 million public offering at $5.75 per share
- Anteris Technologies Global Corp. Announces Pricing of $200 Million Public Offering
- Anteris Technologies Global Corp. Announces Pricing of $200 Million Public Offering
AVR and AVR.AX Related Press Releases
Go Back- Anteris Appoints Susan Knight and Stephen Denaro to its Board of Directors
- Anteris Announces Results for the First Quarter of 2026
- Anteris Technologies Announces First U.S. Patients Treated in Global Pivotal PARADIGM Trial
- Anteris Technologies Secures CMS Reimbursement Supporting U.S. Site Activation for PARADIGM Trial
- Anteris Announces Strategic Investment from Medtronic to Continue Advancing TAVR in $320 Million Aggregate Capital Raises
- Anteris Technologies Global Corp. Announces Closing of $230 Million Public Offering of Common Stock
- Anteris Technologies Global Corp. Announces Pricing of $200 Million Public Offering
- Anteris Technologies Global Corp. Announces Pricing of $200 Million Public Offering
